Vice President, Scientific Strategy
Prolytix
Essex Junction, Vermont, United States
John Maddalena joined Haematologic Technologies in 1992. He was responsible for the development and implementation of a quality management system (QMS) and subsequent ISO 9001 registration to support Prolytix’s manufacturing activities. In 2010, John assumed oversight responsibilities for Prolytix’s GMP operations which focus on providing GMP analytical and bioanalytical testing services to support clinical trials as well as release and stability programs for biotherapeutics. He specializes in the development and validation of analytical test methods. John received his B.S. in microbiology from the University of Notre Dame and his Ph.D. in cellular and molecular biology from the University of Vermont. John also holds an M.Ed. from the University of Massachusetts.
Disclosure information not submitted.
Tuesday, April 25, 2023
1:30 PM – 2:15 PM ET